VRNDF - Delta 9 Cannabis Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.6581
-0.0509 (-7.18%)
At close: 3:55PM EDT
Stock chart is not supported by your current browser
Previous Close0.7090
Open0.6689
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6581 - 0.6689
52 Week Range0.6540 - 1.8500
Volume1,349
Avg. Volume12,131
Market Cap53.231M
Beta (3Y Monthly)9.62
PE Ratio (TTM)N/A
EPS (TTM)-0.1180
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Delta 9 Agrees to Increase Bank Credit Facility to $18.1 Million
    CNW Group

    Delta 9 Agrees to Increase Bank Credit Facility to $18.1 Million

    WINNIPEG , Aug. 14, 2019 /CNW/ - DELTA 9 CANNABIS INC. (TSX-V:DN) (VRNDF) ("Delta 9" or the "Company") is pleased to announce that it has come to terms on an amendment to the Company's borrowing arrangement with Canadian Western Bank (the "Bank") to provide for an increase to its existing loan and credit facility by the addition of certain loan segments and amendments to certain existing loan segments. The changes will bring the Company's total credit facility with the Bank to approximately $18.19 Million . "This increased debt financing, together with our recently completed short form prospectus offering of debenture units have well-positioned us to continue the Company's growth and implementation of its business plan for the remainder of the year," said Delta 9 CEO John Arbuthnot .

  • Delta 9 Receives Conditional Approval to List on TSX
    CNW Group

    Delta 9 Receives Conditional Approval to List on TSX

    WINNIPEG , Aug. 8, 2019 /CNW/ - DELTA 9 CANNABIS INC. (TSX-V:DN) (VRNDF) ("Delta 9" or the "Company") is pleased to announce that is has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange ("TSXV") and list its common shares (the "Common Shares"), Common Share purchase warrants expiring December 28, 2019 (the "2017 Warrants"), Common Share purchase warrants expiring July 17, 2022 (the "2019 Warrants") and 8.5% unsecured convertible debentures (the "Debentures") on the TSX. "We are very excited to be in the final stages of qualifying to be up listed to the TSX.

  • Delta 9 Provides Guidance for Q2, 2019 Results, Anticipating Revenues of $8.1M to $8.8M
    CNW Group

    Delta 9 Provides Guidance for Q2, 2019 Results, Anticipating Revenues of $8.1M to $8.8M

    Based on preliminary results, the Company anticipates revenues for the three-month period ending June 30, 2019 to be between $8.1 million and $8.8 million compared with $715,746 for the three-month period ending June 30, 2018 . Based on preliminary results, the Company anticipates revenues for the six-month period ending June 30, 2019 to be between $13.8 million and $14.5 million for the six-month period ending June 30, 2018 , compared to $1.05 million for the same period the prior year. Management believes that continued revenue growth and disciplined cost management initiatives will allow the Company to achieve positive cashflows from operations in fiscal 2019.

  • Westleaf Signs One Year $4 Million White-Label Cannabis Derivative Product Sale Agreement with an Option to Increase to $16 Million
    CNW Group

    Westleaf Signs One Year $4 Million White-Label Cannabis Derivative Product Sale Agreement with an Option to Increase to $16 Million

    CALGARY , July 24, 2019 /CNW/ - Westleaf Inc. (the "Company" or "Westleaf") (WL.V) (WSLFF), is pleased to announce that its subsidiary, Westleaf Labs LP, has entered into a white labeling agreement with Delta 9 (NINE.V)(VRNDF) to supply approximately $4 million of cannabis derivative products from its large-scale extraction and manufacturing facility located in Calgary , known as The Plant. Under the terms of the agreement, the contract will begin on October 1 , subject to receipt of final license approval from Health Canada, and will carry an initial term of one year, whereby Delta 9 will be required to purchase a minimum of ~$4 million of various white labelled derivative products (such products are expected to include a mix of vape pens, gel caps, tincture oil, and edibles) with an option to increase such amount up to $16 million per year.

  • Delta 9 Signs One-Year White Label Cannabis Derivative Manufacturing Agreement with Westleaf
    CNW Group

    Delta 9 Signs One-Year White Label Cannabis Derivative Manufacturing Agreement with Westleaf

    WINNIPEG , July 24, 2019 /CNW/ - DELTA 9 CANNABIS INC. (TSXV:DN) (VRNDF) ("Delta 9" or the "Company") is pleased to announce that its subsidiary, Delta 9 Bio-Tech Inc., has entered into a one-year white labeling agreement with Westleaf Inc.("Westleaf") (WL.V) (WSLFF) to supply approximately $4 million of cannabis derivative products from Westleaf's large-scale extraction and manufacturing facility located in Calgary , known as The Plant. Under the terms of the agreement, the deliveries of cannabis derivative products will begin on October 1, 2019 subject to receipt of final license approval from Health Canada for The Plant, and will continue an initial term of one year. During this initial year, Delta 9 will be required to purchase a minimum of approximately $4 million of various white labeled cannabis derivative products (subject to regulation, such products are expected to include a mix of vape pens, gel caps, tincture oil, and edibles) with an option to increase such amount up to $16 million per year.

  • Delta 9 Announces Commencement of Trading of Debentures and Warrants and Change of Trading Symbol
    CNW Group

    Delta 9 Announces Commencement of Trading of Debentures and Warrants and Change of Trading Symbol

    WINNIPEG , July 24, 2019 /CNW/ - Delta 9 Cannabis Inc. ("Delta 9" or the "Company") (TSXV:DN) (VRNDF) is pleased to announce that the Company's 8.5% unsecured convertible debentures maturing July 17, 2022 (the "Convertible Debentures") and common share purchase warrants expiring July 17, 2022 (the "Warrants") that were issued pursuant to the Company's short form prospectus offering that closed on July 17, 2019 , will commence trading on the TSX Venture Exchange on the date hereof. The Convertible Debentures will trade under the symbol "DN.DB" and the Warrants will trade under the symbol "DN.WT.A". The Company also wishes to announce that the Company's trading symbol for its common shares has changed from "NINE" to "DN".

  • Delta 9 Announces Closing of $11.8 Million Public Offering of Convertible Debenture Units
    CNW Group

    Delta 9 Announces Closing of $11.8 Million Public Offering of Convertible Debenture Units

    WINNIPEG , July 17, 2019 /CNW/ - Delta 9 Cannabis Inc. ("Delta 9" or the "Company") (NINE.V) (VRNDF) is pleased to announce the closing (the "Closing") of its previously announced public offering (the "Offering") of convertible debenture units of the Company (the "Debenture Units") for aggregate gross proceeds of $11,800,000 . The Offering was led by Mackie Research Capital Corporation and Canaccord Genuity Corp. (together, the "Agents"). The net proceeds received by Delta 9 from the Offering will be used for capital expenditures related to the expansion of Delta 9's production facility, capital expenditures relating to new retail cannabis stores and for general corporate and working capital purposes.

  • GlobeNewswire

    Delta 9 Announces Minimum $10 Million Public Offering of 8.5% Convertible Debenture Units

    Delta 9 Cannabis Inc. (“Delta 9” or the “Company”) (NINE.V) (VRNDF) is pleased to report that its offering, previously announced on June 17, 2019 (the “Offering”), will be for an offering size of a minimum of $10,000,000 and up to $14,000,000. The Offering will be conducted on an agency basis for the issuance of a minimum of 10,000 convertible debenture units (each, a “Convertible Debenture Unit”) and up to 14,000 Convertible Debenture Units at a price of $1,000 per Convertible Debenture Unit. The Offering is being co-led by Mackie Research Capital Corporation, as sole bookrunner, and Canaccord Genuity Corp. as co-lead agents (collectively, the “Agents”).

  • GlobeNewswire

    Delta 9 Announces Public Offering of Convertible Debenture Units

    Delta 9 Cannabis Inc. (“Delta 9” or the “Company”) (NINE.V) (VRNDF) is pleased to announce that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with the securities regulatory authorities in all provinces of Canada (except Québec) in connection with a proposed marketed public offering (the “Offering”) of convertible debenture units (each, a “Convertible Debenture Unit”) at a price of $1,000 per Convertible Debenture Unit. The Offering is being co- led by Mackie Research Capital Corporation, as sole bookrunner, and Canaccord Genuity Corp. as co-lead agents (collectively, the “Agents”). Delta 9 will grant the Agents an option (the “Over-Allotment Option”) to cover over-allotments and for market stabilization purposes, exercisable at any time up to 30 days subsequent to the closing of the Offering, to increase the size of the Offering by up to 15%.

  • CNW Group

    Delta 9 Reports Record Revenue for Q1 2019

    Delta 9 Reports Record Revenue for Q1 2019

  • Benzinga

    Video: Here's A Quick Primer On When To Use The Terms Marijuana, Cannabis And Hemp

    Everyone seems to be using the terms “cannabis” and “marijuana” interchangeably. According to Rod Kight, international hemp and cannabis business law attorney, it’s important to know the difference, especially if you’re talking in legal terms. Rod says marijuana is the most important term to get right because it has legal significance.

  • CNW Group

    Delta 9 Reports Record Revenue for Year End 2018

    Delta 9 Reports Record Revenue for Year End 2018

  • PR Newswire

    Delta 9 Provides Guidance for Fiscal 2018 Results, Anticipating Revenues of $7.6M to $8.4M

    Based on preliminary (unaudited) results, the Company anticipates revenues of between $7.6 million and $8.4 million for the twelve-month period ending December 31, 2018, compared to $944,114 for the same period the prior year. Based on preliminary (unaudited) results, the Company anticipates revenues of between $5.3 million and $6.1 million for the three-month period ending December 31, 2018, compared with $1,251,213 for the three-month period ending September 30, 2018. Management believes that revenue growth and disciplined cost management will allow the Company to achieve positive cashflow in fiscal 2019.

  • Market Exclusive

    Delta 9 Cannabis Gets Authorization For Retail Cannabis In Saskatchewan

    Delta 9 Cannabis Inc. (OTCMKTS:VRNDF) lost 0.54% in the last trading session to close at $1.14 despite the company announcing that they had received authorization from the Saskatchewan Liquor and Gaming Authority to directly supply cannabis to the province's wholesale and retail markets. Expanding the market reach John Arbuthnot, the Chief Executive Officer of Delta […]The post Delta 9 Cannabis Gets Authorization For Retail Cannabis In Saskatchewan appeared first on Market Exclusive.

  • Market Exclusive

    Cannabis Stock News Daily Roundup February 22

    Cannabis News Alimentation Couche-Tard (TSX: ATD.A) (TSX: ATD.B) has signed a deal with Canopy Growth (TSX: WEED) (NYSE: CGC) to launch a premium cannabis retail brand in London, Ontario. Located at 1025 Wellington Road in London, the licensed Tweed store is expected to open in April. Canadians for Fair Access to Medical Marijuana (CFAMM), a […]The post Cannabis Stock News Daily Roundup February 22 appeared first on Market Exclusive.

  • Market Exclusive

    Delta 9 to Raise Cannabis Production, Expand Retail Network

    Canada-based Delta 9 Cannabis (TSXV: NINE) (OTCQX: VRNDF) has unveiled plans to increase its annual cannabis production and retail store chain. The cannabis firm said Feb. 21 that it intends to increase its annual cannabis production capacity to 60,000 kilograms per year by 2022 and expand its retail store network to four stores by the […]The post Delta 9 to Raise Cannabis Production, Expand Retail Network appeared first on Market Exclusive.

  • CNW Group

    Delta 9 Announces Future Expansion Plans Including Increase of Production Capacity to 60,000 Kilograms by 2022

    WINNIPEG , Feb. 21, 2019 /CNW/ - DELTA 9 CANNABIS INC. (NINE.V) (VRNDF) ("Delta 9" or the "Company") is pleased to provide an update on its expansion plans. Highlights include that the Company intends to increase its annual cannabis production capacity to 60,000 kilograms per year by 2022 and the expansion of its retail store network to four stores by the end of the second quarter of, 2019. "Today we are pleased to provide our long-term vision to transform Delta 9's Winnipeg based production facilities into one of the largest cannabis production, processing, extraction and distribution centers in Canada " said CEO, John Arbuthnot .

  • Benzinga

    Every Cannabis Company That Went Public In Canada And The US In January

    After a successful 2018, cannabis companies continued to enjoy their moment in the sun in the first month of 2019. The year kicked off with New York Gov. Andrew Cuomo reiterating his promise to legalize ...

  • CNW Group

    Delta 9 Closes sale of Calgary facility to Westleaf

    WINNIPEG , Feb. 1, 2019 /CNW/ - DELTA 9 CANNABIS INC. (NINE.V) (VRNDF) ("Delta 9" or the "Company") is pleased to announce that effective January 31, 2019 (the "Closing Date") it has closed the previously announced sale of its 50% interest in the Delta West extraction facility to Westleaf Inc. (WL.V) ("Westleaf"). Pursuant to the transaction, Westleaf has issued an aggregate of 5,600,000 common shares in the capital of Westleaf ("Westleaf Shares") to Delta 9 in consideration for the acquisition of Delta 9's 50% interest in the limited partnership that owns the Delta West extraction facility.

  • PR Newswire

    Delta 9 sells interest in Calgary facility to Westleaf for $14.95 Million of Westleaf Shares

    WINNIPEG, Jan. 28, 2019 /PRNewswire/ - DELTA 9 CANNABIS INC. (NINE.V) ("Delta 9" or the "Company") is pleased to announce that it has entered into a definitive agreement ("Definitive Agreement")  to sell its 50% interest in the Delta West extraction facility to Westleaf Inc. (WL.V) ("Westleaf"). Under the Definitive Agreement, Westleaf has agreed to issue an aggregate of 5,600,000 common shares in the capital of Westleaf ("Westleaf Shares") in consideration for the acquisition of Delta 9's 50% interest in the project (the "Purchase Price").